Patent details

EP2756004 Title: INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) FOR USE IN REDUCING LIPOPROTEIN(a) LEVELS

Basic Information

Publication number:
EP2756004
PCT Application Number:
US2012054756
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127618643
PCT Publication Number:
WO2013039969
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) FOR USE IN REDUCING LIPOPROTEIN(a) LEVELS
French Title of Invention:
INHIBITEUR DE PROPROTÉINE CONVERTASE SUBTILISINE/KEXINE-9 (PCSK9) POUR L'UTILISATION DANS LA RÉDUCTION DU TAUX DE LIPOPROTÉINE(a)
German Title of Invention:
INHIBITOR VON PROPROTEIN-KONVERTASE-SUBTILISIN KEXIN-9 (PCSK9) ZUR VERWENDUNG FUR DIE REDUZIERUNG DES LIPOPROTEIN Lp(a)-WERTE
SPC Number:

Dates

Filing date:
12/09/2012
Grant date:
25/12/2019
EP Publication Date:
23/07/2014
PCT Publication Date:
21/03/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/12/2019
EP B1 Publication Date:
25/12/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/09/2020
Expiration date:
12/09/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/12/2019
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Inventor

Name:
SWERGOLD, Gary
Address:
United States (US)

Priority

1

Priority Number:
201161535392 P
Priority Date:
16/09/2011
Priority Country:
United States (US)

2

Priority Number:
201161559162 P
Priority Date:
14/11/2011
Priority Country:
United States (US)

3

Priority Number:
201261641321 P
Priority Date:
02/05/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 39/395; A61P 3/06; C07K 16/40;

Publication

European Patent Bulletin

1

Issue number:
201952
Publication date:
25/12/2019
Description:
Grant (B1)

2

Issue number:
202008
Publication date:
19/02/2020
Description:
Opposition procedure started

3

Issue number:
202421
Publication date:
22/05/2024
Description:
Opposition rejected; Patent maintained as granted

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages